Top

Intensive Care Medicine

Published in:

01-09-2020 | SARS-CoV-2 | Letter

Severe COVID-19 is associated with deep and sustained multifaceted cellular immunosuppression

Authors: Robin Jeannet, Thomas Daix, Rémy Formento, Jean Feuillard, Bruno François

Published in: Intensive Care Medicine | Issue 9/2020

Excerpt

Dear Editor, …

Available only for authorised users

Wang Y, Liu Y, Liu L, Wang X, Luo N, Ling L (2020) Clinical outcome of 55 asymptomatic cases at the time of hospital admission infected with SARS-coronavirus-2 in Shenzhen, China. J Infect Dis. https://doi.org/10.1093/infdis/jiaa119CrossRefPubMedPubMedCentral

Chen G, Wu D, Guo W, Cao Y, Huang D, Wang H, Wang T, Zhang X, Chen H, Yu H, Zhang X, Zhang M, Wu S, Song J, Chen T, Han M, Li S, Luo X, Zhao J, Ning Q (2019) Clinical and immunological features of severe and moderate coronavirus disease 2019. J Clin Invest. https://doi.org/10.1172/JCI137244CrossRefPubMedPubMedCentral

Saison J, Demaret J, Venet F, Chidiac C, Malcus C, Poitevin-Later F, Tardy JC, Ferry T, Monneret G (2013) CD4 + CD25 + CD127-assessment as a surrogate phenotype for FOXP3 + regulatory T cells in HIV-1 infected viremic and aviremic subjects. Cytometry B Clin Cytom 84(1):50–54. https://doi.org/10.1002/cyto.b.21047CrossRefPubMed

Vardhana SA, Wolchok JD (2020) The many faces of the anti-COVID immune response. J Exp Med 217(6):e20200678. https://doi.org/10.1084/jem.20200678CrossRefPubMedPubMedCentral

Hotchkiss RS, Monneret G, Payen D (2013) Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach. Lancet Infect Dis 13(3):260–268. https://doi.org/10.1016/S1473-3099(13)70001-XCrossRefPubMedPubMedCentral

Francois B, Jeannet R, Daix T, Walton AH, Shotwell MS, Unsinger J, Monneret G, Rimmelé T, Blood T, Morre M, Gregoire A, Mayo GA, Blood J, Durum SK, Sherwood ER, Hotchkiss RS (2018) Interleukin-7 restores lymphocytes in septic shock: the IRIS-7 randomized clinical trial. JCI Insight 3(5):e98960. https://doi.org/10.1172/jci.insight.98960CrossRefPubMedCentral

Title: Severe COVID-19 is associated with deep and sustained multifaceted cellular immunosuppression
Authors: Robin Jeannet
Thomas Daix
Rémy Formento
Jean Feuillard
Bruno François
Publication date: 01-09-2020
Publisher: Springer Berlin Heidelberg
Keywords: SARS-CoV-2
Lymphopenia
COVID-19
Published in: Intensive Care Medicine / Issue 9/2020
Print ISSN: 0342-4642
Electronic ISSN: 1432-1238
DOI: https://doi.org/10.1007/s00134-020-06127-x

At a glance: The STEP trials

Springer Medicine

Severe COVID-19 is associated with deep and sustained multifaceted cellular immunosuppression

Excerpt

At a glance: The STEP trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 9/2020

Focus on gastrointestinal system in critically ill patients

Antibiotics in the ICU; benefit or harm?

Early bacterial co-infection in ARDS related to COVID-19

Less contact isolation is more in the ICU: pro

Histological–ultrasonographical correlation of pulmonary involvement in severe COVID-19

Single lung with bilateral pneumothorax